EPAS1 and pulmonary arterial hypertension: For example, ROS induces increased expression of HIF-2α, which in turn promotes vascular remodeling and the development of pulmonary arterial hypertension (PAH) by upregulating SNAI that induces endothelium-mesenchymal transdifferentiation [52, 53].